416 results
Top cases of AICT-AsiaPCR 2023
21 Sep 2023 – From AICT-AsiaPCR 2023
Discover the most intriguing cases featured at AICT-AsiaPCR 2023 in this session: from adrenaline surges to complex primary PCIs gone haywire, from CHIP protected PCI in AMICS to complex CTO of an anomalous RCA, dive into these real-world cases and gain valuable insights that expand your...
Challenges in calcified lesions
21 Sep 2023 – From AICT-AsiaPCR 2023
Explore a variety of challenging cases in this session, from the perplexing uncrossable STEMI to the specialized "Blocked" balloon anchoring technique, the unique challenges of calcified lesions in elderly patients to the debulking of a calcified nodule within the left circumflex ostium through the stent strut,...
Left main interventions: cutting-edge insights
21 Sep 2023 – From AICT-AsiaPCR 2023
Join us in this session on left main interventions and explore the challenges and strategies for left main PCI in complex cases, from minimalist approaches in limited-resource settings to complex procedures like percutaneous transluminal coronary angioplasty with IVUS guidance.
Revolutionising coronary calcium treatment: unleashing the potential of intravascular lithotripsy
21 Sep 2023 – From AICT-AsiaPCR 2023
Over the last five years, we have learned that there is a new tool for treating calcium, the greatest enemy of interventional cardiology, which can take various forms: intravascular lithotripsy. In this session, look at how to master this technique in different scenarios, from eccentric calcified...
Shock the rock with more IVL impulses, and get more gain!
20 Sep 2023
How would you treat this 81-year-old male patient with HTN, diabetes, dyslipidemia, peripheral vasculopathy, previous coronary angioplasty and prostatic adenocarcinoma, who was admitted for effort angina and positive stress test?
Author
Author
Author
MULTISTARS AMI: Multivessel immediate versus staged revascularization in STEMI
28 Aug 2023
Aaysha Cader interviews Barbara Elisabeth Stahli on the study design and results that she presented during the ESC Congress 2023 in Amsterdam.
Immediate multivessel PCI was non-inferior to staged multivessel PCI for reducing death and ischemic events in patients with STEMI and multivessel coronary artery disease.
Author
Author
FIRE trial: physiology-guided complete PCI in older MI patients
27 Aug 2023
Luis Ortega-Paz interviews Simone Biscaglia and Gianluca Campo about the FIRE trial.
Results showed elderly patients presenting with either STEMI or NSTEMI benefit from complete revascularization, reducing cardiovascular events risk at 1 year compared to culprit lesion-only PCI.
Published simultaneously in the New England Journal of Medicine
Author
Author
Author
Percutaneous coronary intervention vs coronary artery bypass graft surgery for left main disease in patients with and without acute coronary syndromes: a pooled analysis of 4 randomized clinical trials
05 Jul 2023
This patient-level analysis of randomized trials comparing PCI vs CABG for the treatment of low-to-intermediate CAD involving the LM confirms the absence of long-term differences in mortality between revascularization techniques, regardless of the clinical presentation.
Reviewer
Reviewer
PCI or CABG for left main coronary artery disease: the SWEDEHEART registry
28 Jun 2023
While the choice between PCI and CABG for LMCA disease continues to be one of the most controversial topics, patient characteristics & comorbidities must be taken into account, as must the external validity of the results of RCTs in the real world, as the SWEDEHEART registry does.
Reviewer
Reviewer
Die Hard: high-risk PCI in calcified LM and severe LV dysfunction
14 Jun 2023
How would you treat an extremely calcified sub-occluded LM in a 72-year-old man presenting on "dependent stability and sliding on inotropes"(*), refused by surgery?
(*) INTERMACS III to II
Author
Author
Author
